News E.U. gives thumbs up for belantamab in R/R multiple myeloma Author: Zosia Chustecka Publish date: July 28, 2020 The first-in-class drug belantamab mafodotin (Blenrep, GlaxoSmithKline) has been recommended for conditional... Read More
